© 2020 MJH Life Sciences and Formulary Watch. All rights reserved.
Diabetes and Endocrinology
Two metformin products recalled, more on the way
June 02, 2020
Immediately after the FDA said it found elevated levels of the carcinogenic ingredient N-nitrosodimethylamine (NDMA) in certain extended release (ER) metformin products, the first 2 major recalls are underway.
Pharma exec: New type 2 diabetes treatment competitively priced
September 24, 2019
How the first oral GLP-1 oral treatment for type 2 diabetes is unique and how it will be priced compared to other GLP-1 medications.
FDA clears first ready-to-use insulin for IV infusion
July 22, 2019
FDA approved the first and only ready-to-use insulin for IV infusion in hospitals and acute care settings.
FDA fast tracks blockbuster diabetes drug for heart failure
July 08, 2019
FDA granted Fast Track designation to a popular diabetes drug to reduce the risk of cardiovascular death and hospitalization for heart failure in people with chronic heart failure.
Lack of insulin competition high priority for FDA
April 02, 2019
FDA fast-tracks biosimiliar insulin products to elevate competition.
FDA clears novel diabetes, tropical disease therapies
February 19, 2019
FDA approved first interoperable insulin pump, as well as the only FDA-approved drug for patients with a neglected tropical disease.
Overtreating glucose levels can take a toll on diabetes patients
July 29, 2016
Mayo Clinic researchers found that beyond overtesting, focus on HbA1C levels can lead to serious harms for patients, especially as more diabetes drugs are needed to keep HbA1C within desired targets.
Wide geographic differences exist in treating diabetes
July 29, 2016
A large-scale observational study led by Columbia University researchers may offer new approach to studying diverse patient groups.